Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. FDX
5. IBM
6. MU
7. META
8. USO
9. NVDA
10. BLZE

Go back to Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength
ARISTOTLE (NASDAQ: ARTL) Delayed: 1.26 +0.03 (2.44%)
Previous Close $1.23    52 Week High $6.22 
Open $1.23    52 Week Low $2.74 
Day High $1.29    P/E N/A 
Day Low $1.21    EPS $-0.21 
Volume 242,113